Antimicrobial spinel ferrite treatment composition
US-12006226-B2 · Jun 11, 2024 · US
US12227429B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12227429-B2 |
| Application number | US-202418639176-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 18, 2024 |
| Priority date | Jan 17, 2019 |
| Publication date | Feb 18, 2025 |
| Grant date | Feb 18, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods of forming spinel ferrite nanoparticles containing a chromium-substituted copper ferrite as well as properties (e.g. particle size, crystallite size, pore size, surface area) of these spinel ferrite nanoparticles are described. Methods of preventing or reducing microbe growth on a surface by applying these spinel ferrite nanoparticles onto the surface in the form of a suspension or an antimicrobial product are also described.
Opening claim text (preview).
The invention claimed is: 1. A CuCrFe oxide antimicrobial treatment composition, comprising: spinel ferrite nanoparticles, and a liquid medium; wherein the spinel ferrite nanoparticles comprise at least one chromium-substituted copper ferrite selected from the group consisting of CuCr 0.4 Fe 1.6 O 4 , CuCr 0.6 Fe 1.4 O 4 , and CuCr 0.8 Fe 1.2 O 4 , and wherein the spinel ferrite nanoparticles have an angular, spinel, or irregular form, and are suspended in the liquid medium. 2. The antimicrobial treatment composition of claim 1 , comprising the spinel ferrite nanoparticles in an amount of 50 μg/mL to 100 mg/mL. 3. The antimicrobial treatment composition of claim 1 , wherein the liquid medium is water. 4. The antimicrobial treatment composition of claim 1 , comprising a chromium-substituted copper ferrite having the formula CuCr 0.4 Fe 1.6 O 4 . 5. The antimicrobial treatment composition of claim 1 , comprising a chromium-substituted copper ferrite having the formula CuCr 0.6 Fe 1.4 O 4 . 6. The antimicrobial treatment composition of claim 1 , comprising a chromium-substituted copper ferrite having the formula CuCr 0.8 Fe 1.2 O 4 . 7. The antimicrobial treatment composition of claim 1 , wherein the spinel ferrite nanoparticles have a crystallite size of from 43.3 to 20.2 nm. 8. The antimicrobial treatment composition of claim 1 , wherein the spinel ferrite nanoparticles have spherical morphology and an average particle size of from 73.5 to 47.6 nm. 9. The antimicrobial treatment composition of claim 1 , wherein the spinel ferrite nanoparticles have an average particle size in a range of 20-90 nm. 10. The antimicrobial treatment composition of claim 1 , wherein the spinel ferrite nanoparticles are porous. 11. The antimicrobial treatment composition of claim 1 , wherein the spinel ferrite nanoparticles have a BET surface area in a range of 8-30 m 2 /g. 12. The antimicrobial treatment composition of claim 1 , wherein the spinel ferrite nanoparticles have an optical band gap energy value of 1.0-2.0 eV.
spinel-type (AB2O4) · CPC title
Manufacture or treatment of nanostructures · CPC title
by IR- or Raman-data · CPC title
by d-values or two theta-values, e.g. as X-ray diagram · CPC title
Nanotechnology for materials or surface science, e.g. nanocomposites · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.